|
Delayed
Nasdaq
09:21:20 03/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.855 USD | +6.79% |
|
-2.90% | -34.33% |
| 19/10 | Clene Inc. Submits New Drug Application to Fda for Cnm-Au8 for the Treatment of Als | CI |
| 16/09 | Top Midday Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLENE INC. | Bio Therapeutic Drugs | +6.79% | -2.90% | -34.33% | -67.82% | -95.93% | 5.13Cr |  |  | |
- Stock Market
- Stocks
- CLNN Stock
- Charts Clene Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
